Perspective TherapeuticsCATX
13F holders, Q4 2025 (December 31)2holders
0new positions
0sold out
$13.40avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Vestor Capital, LLC ($2.7M) and Portland Investment Counsel Inc. ($688K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 971,474 shares sold, net −971,474 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Vestor Capital, LLC | 0.22% | Reduce -100.0% | 502 | $2.7M |
| Portland Investment Counsel Inc. | 0.21% | No change | 250,000 | $688K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.